Crestwood Advisors Group LLC Ultragenyx Pharmaceutical Inc. Transaction History

Crestwood Advisors Group LLC

$4.74 Billion
Q2 2024

A detailed history of Crestwood Advisors Group LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 100,280 shares of RARE stock, worth $5.89 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

100,280

Previous 100,258 0.02%

Holding current value

$5.89 Million

Previous $4.68 Million 11.96%

% of portfolio

0.09%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$37.42 - $51.61 $823 - $1,135	22 Added 0.02%	100,280 $4.12 Million
Q3 2023 Nov 15, 2023	BUY	$34.92 - $46.66 $2.46 Million - $3.28 Million	70,350 Added 235.22%	100,258 $3.57 Million
Q1 2021 Apr 21, 2021	SELL	$106.9 - $167.73 $117,590 - $184,503	-1,100 Reduced 3.55%	29,908 $3.41 Million
Q3 2020 Oct 06, 2020	SELL	$72.98 - $90.0 $80,278 - $99,000	-1,100 Reduced 3.43%	31,008 $2.55 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $46,910 - $78,220	-1,000 Reduced 3.02%	32,108 $2.51 Million
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $13,519 - $25,160	400 Added 1.22%	33,108 $1.47 Million
Q4 2019 Feb 12, 2020	SELL	$36.08 - $45.83 $9,020 - $11,457	-250 Reduced 0.76%	32,708 $1.4 Million
Q3 2019 Nov 13, 2019	BUY	$42.5 - $63.11 $10,625 - $15,777	250 Added 0.76%	32,958 $1.41 Million
Q4 2018 Feb 14, 2019	SELL	$38.89 - $77.3 $19,445 - $38,650	-500 Reduced 1.51%	32,708 $1.42 Million
Q2 2018 Aug 14, 2018	BUY	$48.54 - $85.31 $558,210 - $981,065	11,500 Added 52.98%	33,208 $0
Q1 2018 May 14, 2018	BUY	$44.33 - $58.52 $22,165 - $29,260	500 Added 2.36%	21,708 $1.11 Million
Q3 2017 Nov 20, 2017	BUY	$49.79 - $66.32 $1.06 Million - $1.41 Million	21,208	21,208 $1.13 Million

Others Institutions Holding RARE

# of Institutions

287

Shares Held

88.1M

Call Options Held

505K

Put Options Held

198K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $4.11B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Account

Crestwood Advisors Group LLC Ultragenyx Pharmaceutical Inc. Transaction History